354 related articles for article (PubMed ID: 25909848)
1. BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses.
Young K; Tweedie E; Conley B; Ames J; FitzSimons M; Brooks P; Liaw L; Vary CP
PLoS One; 2015; 10(4):e0122892. PubMed ID: 25909848
[TBL] [Abstract][Full Text] [Related]
2. BMP9 regulates endoglin-dependent chemokine responses in endothelial cells.
Young K; Conley B; Romero D; Tweedie E; O'Neill C; Pinz I; Brogan L; Lindner V; Liaw L; Vary CP
Blood; 2012 Nov; 120(20):4263-73. PubMed ID: 23018639
[TBL] [Abstract][Full Text] [Related]
3. Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies.
Nolan-Stevaux O; Zhong W; Culp S; Shaffer K; Hoover J; Wickramasinghe D; Ruefli-Brasse A
PLoS One; 2012; 7(12):e50920. PubMed ID: 23300529
[TBL] [Abstract][Full Text] [Related]
4. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells.
Xu S; Koroleva M; Yin M; Jin ZG
Transl Res; 2016 Oct; 176():18-28.e2. PubMed ID: 27295628
[TBL] [Abstract][Full Text] [Related]
5. Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain.
Conley BA; Koleva R; Smith JD; Kacer D; Zhang D; Bernabéu C; Vary CP
J Biol Chem; 2004 Jun; 279(26):27440-9. PubMed ID: 15084601
[TBL] [Abstract][Full Text] [Related]
6. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
7. Endoglin mediates fibronectin/α5β1 integrin and TGF-β pathway crosstalk in endothelial cells.
Tian H; Mythreye K; Golzio C; Katsanis N; Blobe GC
EMBO J; 2012 Oct; 31(19):3885-900. PubMed ID: 22940691
[TBL] [Abstract][Full Text] [Related]
8. Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains.
Kienast Y; Jucknischke U; Scheiblich S; Thier M; de Wouters M; Haas A; Lehmann C; Brand V; Bernicke D; Honold K; Lorenz S
J Biol Chem; 2016 Feb; 291(7):3395-410. PubMed ID: 26677222
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.
Nishio M; Sugimachi K; Goto H; Wang J; Morikawa T; Miyachi Y; Takano Y; Hikasa H; Itoh T; Suzuki SO; Kurihara H; Aishima S; Leask A; Sasaki T; Nakano T; Nishina H; Nishikawa Y; Sekido Y; Nakao K; Shin-Ya K; Mimori K; Suzuki A
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E71-80. PubMed ID: 26699479
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
[TBL] [Abstract][Full Text] [Related]
11. The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells.
Lee NY; Blobe GC
J Biol Chem; 2007 Jul; 282(29):21507-17. PubMed ID: 17540773
[TBL] [Abstract][Full Text] [Related]
12. Endoglin regulates PI3-kinase/Akt trafficking and signaling to alter endothelial capillary stability during angiogenesis.
Lee NY; Golzio C; Gatza CE; Sharma A; Katsanis N; Blobe GC
Mol Biol Cell; 2012 Jul; 23(13):2412-23. PubMed ID: 22593212
[TBL] [Abstract][Full Text] [Related]
13. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function.
Mallet C; Lamribet K; Giraud S; Dupuis-Girod S; Feige JJ; Bailly S; Tillet E
Hum Mol Genet; 2015 Feb; 24(4):1142-54. PubMed ID: 25312062
[TBL] [Abstract][Full Text] [Related]
15. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.
Azuma H
J Med Invest; 2000 Aug; 47(3-4):81-90. PubMed ID: 11019486
[TBL] [Abstract][Full Text] [Related]
16. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth.
Castonguay R; Werner ED; Matthews RG; Presman E; Mulivor AW; Solban N; Sako D; Pearsall RS; Underwood KW; Seehra J; Kumar R; Grinberg AV
J Biol Chem; 2011 Aug; 286(34):30034-46. PubMed ID: 21737454
[TBL] [Abstract][Full Text] [Related]
17. Integrin-β5 and zyxin mediate formation of ventral stress fibers in response to transforming growth factor β.
Bianchi-Smiraglia A; Kunnev D; Limoge M; Lee A; Beckerle MC; Bakin AV
Cell Cycle; 2013 Nov; 12(21):3377-89. PubMed ID: 24036928
[TBL] [Abstract][Full Text] [Related]
18. Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC.
Lee NY; Ray B; How T; Blobe GC
J Biol Chem; 2008 Nov; 283(47):32527-33. PubMed ID: 18775991
[TBL] [Abstract][Full Text] [Related]
19. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex.
Blanco FJ; Santibanez JF; Guerrero-Esteo M; Langa C; Vary CP; Bernabeu C
J Cell Physiol; 2005 Aug; 204(2):574-84. PubMed ID: 15702480
[TBL] [Abstract][Full Text] [Related]
20. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
